Attendance and vaccination at immunization clinics in rural Gambia before and during the COVID-19 pandemic
•Average monthly EPI attendance reduced by 13.4% during the COVID interrupted period.•Average monthly immunizations were reduced by 38.3% during the interruption period.•Highest decline was observed in vaccines given early in infancy.•Reduced EPI attendance during the pandemic interruption period la...
Gespeichert in:
| Veröffentlicht in: | Vaccine 2022-10, Vol.40 (44), p.6367-6373 |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 6373 |
|---|---|
| container_issue | 44 |
| container_start_page | 6367 |
| container_title | Vaccine |
| container_volume | 40 |
| creator | Osei, Isaac Sarwar, Golam Hossain, Ilias Sonko, Kemo Ceesay, Lamin Baldeh, Bubacarr Secka, Ebba Mackenzie, Grant A |
| description | •Average monthly EPI attendance reduced by 13.4% during the COVID interrupted period.•Average monthly immunizations were reduced by 38.3% during the interruption period.•Highest decline was observed in vaccines given early in infancy.•Reduced EPI attendance during the pandemic interruption period lasted only 3 months.•Mothers were comfortable to re-start EPI attendance with older than younger infants.
The COVID-19 pandemic has affected the delivery of essential health services, such as routine immunization. We assessed the impact of the pandemic on the uptake of routine immunization in rural Gambia.
We collected real-time vaccine administration data in the Basse and Fuladu West Health & Demographic Surveillance Systems from September 01, 2019, to December 31, 2020. We assessed the monthly number of Expanded Program on Immunization (EPI) clinic attendances and vaccines administered, comparing data during the baseline period (September 01, 2019–March 31, 2020), COVID-19 interruption period (April 01–June 30, 2020), initial recovery period (Jul 01–September 30, 2020) and the late recovery period (October 01–December 31, 2020).
Compared to the baseline period, there was an overall average monthly decline of 13.4% in EPI attendance and 38.3% reduction in average monthly immunizations during the interruption period. This decrease was particularly noticeable for Bacille Calmette-Guérin (BCG) (47.2%), birth dose hepatitis B (Hep B) (46.9%), 1st dose pentavalent (Penta1) (43.1%), 1st dose pneumococcal conjugate vaccine (PCV1) (42.4%), and measles vaccines (15.5%). Comparing the late recovery to baseline period, average monthly EPI attendance was 5.3% higher, with 1.9% increase in average monthly immunizations. Monthly immunizations for BCG were 3.0% greater, 2.5% greater for Hep B, 22.7% greater for oral polio vaccine (OPV1), 2.0% less for Penta1, 19.2% less for Penta2, and 2.6% less for PCV1.
The reduced EPI attendance during the pandemic interruption period lasted only 3 months. Significant recovery in EPI attendance occurred during the late recovery period, while rates of monthly immunization returned to pre-pandemic levels for most antigens. EPI programmes should implement strategies to deliver missed antigens when infants do present to EPI clinics, aware that missed doses may be age dependent. |
| doi_str_mv | 10.1016/j.vaccine.2022.09.031 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9468317</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0264410X22011252</els_id><sourcerecordid>2724994148</sourcerecordid><originalsourceid>FETCH-LOGICAL-c495t-45d113de3d0b8ce462dea730a2aca74fa6897766adceddb79a3a76f0d009bc613</originalsourceid><addsrcrecordid>eNqFkU1v1DAQhi0EokvhJ4AsceklwV-x4wuoWqBUqtQLIG7WxHZaRxtnsZOV4NfjVZYKuHCyrHnm9YwfhF5SUlNC5ZuhPoC1IfqaEcZqomvC6SO0oa3iFWto-xhtCJOiEpR8O0PPch4IIQ2n-ik645K2hCuxQcPlPPvoIFqPITq8hsIcpohhxmEclxh-rne7CzHYjEPEaUmww1cwdgFw5_spre1uSSHe4fne4-3t1-v3FdV4Xwp-DPY5etLDLvsXp_Mcffn44fP2U3Vze3W9vbyprNDNXInGUcqd5450rfVCMudBcQIMLCjRg2y1UlKCs965TmngoGRPHCG6s5Lyc_R2zd0v3egLFecyrNmnMEL6YSYI5u9KDPfmbjoYLWTLqSoBF6eANH1ffJ7NGLL1ux1EPy3ZMMWIYC2lpKCv_0GHaUmxrHekhNaCirZQzUrZNOWcfP8wDCXmaNMM5mTTHG0aok2xWfpe_bnJQ9dvfQV4twK-_Och-GSyDb64dCF5Oxs3hf888Qv2krS1</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2724994148</pqid></control><display><type>article</type><title>Attendance and vaccination at immunization clinics in rural Gambia before and during the COVID-19 pandemic</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Osei, Isaac ; Sarwar, Golam ; Hossain, Ilias ; Sonko, Kemo ; Ceesay, Lamin ; Baldeh, Bubacarr ; Secka, Ebba ; Mackenzie, Grant A</creator><creatorcontrib>Osei, Isaac ; Sarwar, Golam ; Hossain, Ilias ; Sonko, Kemo ; Ceesay, Lamin ; Baldeh, Bubacarr ; Secka, Ebba ; Mackenzie, Grant A</creatorcontrib><description>•Average monthly EPI attendance reduced by 13.4% during the COVID interrupted period.•Average monthly immunizations were reduced by 38.3% during the interruption period.•Highest decline was observed in vaccines given early in infancy.•Reduced EPI attendance during the pandemic interruption period lasted only 3 months.•Mothers were comfortable to re-start EPI attendance with older than younger infants.
The COVID-19 pandemic has affected the delivery of essential health services, such as routine immunization. We assessed the impact of the pandemic on the uptake of routine immunization in rural Gambia.
We collected real-time vaccine administration data in the Basse and Fuladu West Health & Demographic Surveillance Systems from September 01, 2019, to December 31, 2020. We assessed the monthly number of Expanded Program on Immunization (EPI) clinic attendances and vaccines administered, comparing data during the baseline period (September 01, 2019–March 31, 2020), COVID-19 interruption period (April 01–June 30, 2020), initial recovery period (Jul 01–September 30, 2020) and the late recovery period (October 01–December 31, 2020).
Compared to the baseline period, there was an overall average monthly decline of 13.4% in EPI attendance and 38.3% reduction in average monthly immunizations during the interruption period. This decrease was particularly noticeable for Bacille Calmette-Guérin (BCG) (47.2%), birth dose hepatitis B (Hep B) (46.9%), 1st dose pentavalent (Penta1) (43.1%), 1st dose pneumococcal conjugate vaccine (PCV1) (42.4%), and measles vaccines (15.5%). Comparing the late recovery to baseline period, average monthly EPI attendance was 5.3% higher, with 1.9% increase in average monthly immunizations. Monthly immunizations for BCG were 3.0% greater, 2.5% greater for Hep B, 22.7% greater for oral polio vaccine (OPV1), 2.0% less for Penta1, 19.2% less for Penta2, and 2.6% less for PCV1.
The reduced EPI attendance during the pandemic interruption period lasted only 3 months. Significant recovery in EPI attendance occurred during the late recovery period, while rates of monthly immunization returned to pre-pandemic levels for most antigens. EPI programmes should implement strategies to deliver missed antigens when infants do present to EPI clinics, aware that missed doses may be age dependent.</description><identifier>ISSN: 0264-410X</identifier><identifier>EISSN: 1873-2518</identifier><identifier>DOI: 10.1016/j.vaccine.2022.09.031</identifier><identifier>PMID: 36180374</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><subject>Antigens ; BCG Vaccine ; Children & youth ; Clinics ; Coronaviruses ; COVID-19 ; COVID-19 - epidemiology ; COVID-19 - prevention & control ; COVID-19 vaccines ; Data collection ; Electronic vaccination records ; Gambia - epidemiology ; Health services ; Hepatitis ; Hepatitis B ; Humans ; Immunization ; Immunization Programs ; Immunization Schedule ; Immunization services ; Infant ; Measles ; Medical research ; Pandemic ; Pandemics ; Pandemics - prevention & control ; Poliomyelitis ; Population ; Public health ; Recovery ; Rotavirus ; State of emergency ; Surveillance systems ; Vaccination ; Vaccines ; Vaccines, Conjugate ; Viruses ; Whooping cough</subject><ispartof>Vaccine, 2022-10, Vol.40 (44), p.6367-6373</ispartof><rights>2022 Elsevier Ltd</rights><rights>Copyright © 2022 Elsevier Ltd. All rights reserved.</rights><rights>2022. Elsevier Ltd</rights><rights>2022 Elsevier Ltd. All rights reserved. 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c495t-45d113de3d0b8ce462dea730a2aca74fa6897766adceddb79a3a76f0d009bc613</citedby><cites>FETCH-LOGICAL-c495t-45d113de3d0b8ce462dea730a2aca74fa6897766adceddb79a3a76f0d009bc613</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0264410X22011252$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,776,780,881,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36180374$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Osei, Isaac</creatorcontrib><creatorcontrib>Sarwar, Golam</creatorcontrib><creatorcontrib>Hossain, Ilias</creatorcontrib><creatorcontrib>Sonko, Kemo</creatorcontrib><creatorcontrib>Ceesay, Lamin</creatorcontrib><creatorcontrib>Baldeh, Bubacarr</creatorcontrib><creatorcontrib>Secka, Ebba</creatorcontrib><creatorcontrib>Mackenzie, Grant A</creatorcontrib><title>Attendance and vaccination at immunization clinics in rural Gambia before and during the COVID-19 pandemic</title><title>Vaccine</title><addtitle>Vaccine</addtitle><description>•Average monthly EPI attendance reduced by 13.4% during the COVID interrupted period.•Average monthly immunizations were reduced by 38.3% during the interruption period.•Highest decline was observed in vaccines given early in infancy.•Reduced EPI attendance during the pandemic interruption period lasted only 3 months.•Mothers were comfortable to re-start EPI attendance with older than younger infants.
The COVID-19 pandemic has affected the delivery of essential health services, such as routine immunization. We assessed the impact of the pandemic on the uptake of routine immunization in rural Gambia.
We collected real-time vaccine administration data in the Basse and Fuladu West Health & Demographic Surveillance Systems from September 01, 2019, to December 31, 2020. We assessed the monthly number of Expanded Program on Immunization (EPI) clinic attendances and vaccines administered, comparing data during the baseline period (September 01, 2019–March 31, 2020), COVID-19 interruption period (April 01–June 30, 2020), initial recovery period (Jul 01–September 30, 2020) and the late recovery period (October 01–December 31, 2020).
Compared to the baseline period, there was an overall average monthly decline of 13.4% in EPI attendance and 38.3% reduction in average monthly immunizations during the interruption period. This decrease was particularly noticeable for Bacille Calmette-Guérin (BCG) (47.2%), birth dose hepatitis B (Hep B) (46.9%), 1st dose pentavalent (Penta1) (43.1%), 1st dose pneumococcal conjugate vaccine (PCV1) (42.4%), and measles vaccines (15.5%). Comparing the late recovery to baseline period, average monthly EPI attendance was 5.3% higher, with 1.9% increase in average monthly immunizations. Monthly immunizations for BCG were 3.0% greater, 2.5% greater for Hep B, 22.7% greater for oral polio vaccine (OPV1), 2.0% less for Penta1, 19.2% less for Penta2, and 2.6% less for PCV1.
The reduced EPI attendance during the pandemic interruption period lasted only 3 months. Significant recovery in EPI attendance occurred during the late recovery period, while rates of monthly immunization returned to pre-pandemic levels for most antigens. EPI programmes should implement strategies to deliver missed antigens when infants do present to EPI clinics, aware that missed doses may be age dependent.</description><subject>Antigens</subject><subject>BCG Vaccine</subject><subject>Children & youth</subject><subject>Clinics</subject><subject>Coronaviruses</subject><subject>COVID-19</subject><subject>COVID-19 - epidemiology</subject><subject>COVID-19 - prevention & control</subject><subject>COVID-19 vaccines</subject><subject>Data collection</subject><subject>Electronic vaccination records</subject><subject>Gambia - epidemiology</subject><subject>Health services</subject><subject>Hepatitis</subject><subject>Hepatitis B</subject><subject>Humans</subject><subject>Immunization</subject><subject>Immunization Programs</subject><subject>Immunization Schedule</subject><subject>Immunization services</subject><subject>Infant</subject><subject>Measles</subject><subject>Medical research</subject><subject>Pandemic</subject><subject>Pandemics</subject><subject>Pandemics - prevention & control</subject><subject>Poliomyelitis</subject><subject>Population</subject><subject>Public health</subject><subject>Recovery</subject><subject>Rotavirus</subject><subject>State of emergency</subject><subject>Surveillance systems</subject><subject>Vaccination</subject><subject>Vaccines</subject><subject>Vaccines, Conjugate</subject><subject>Viruses</subject><subject>Whooping cough</subject><issn>0264-410X</issn><issn>1873-2518</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqFkU1v1DAQhi0EokvhJ4AsceklwV-x4wuoWqBUqtQLIG7WxHZaRxtnsZOV4NfjVZYKuHCyrHnm9YwfhF5SUlNC5ZuhPoC1IfqaEcZqomvC6SO0oa3iFWto-xhtCJOiEpR8O0PPch4IIQ2n-ik645K2hCuxQcPlPPvoIFqPITq8hsIcpohhxmEclxh-rne7CzHYjEPEaUmww1cwdgFw5_spre1uSSHe4fne4-3t1-v3FdV4Xwp-DPY5etLDLvsXp_Mcffn44fP2U3Vze3W9vbyprNDNXInGUcqd5450rfVCMudBcQIMLCjRg2y1UlKCs965TmngoGRPHCG6s5Lyc_R2zd0v3egLFecyrNmnMEL6YSYI5u9KDPfmbjoYLWTLqSoBF6eANH1ffJ7NGLL1ux1EPy3ZMMWIYC2lpKCv_0GHaUmxrHekhNaCirZQzUrZNOWcfP8wDCXmaNMM5mTTHG0aok2xWfpe_bnJQ9dvfQV4twK-_Och-GSyDb64dCF5Oxs3hf888Qv2krS1</recordid><startdate>20221019</startdate><enddate>20221019</enddate><creator>Osei, Isaac</creator><creator>Sarwar, Golam</creator><creator>Hossain, Ilias</creator><creator>Sonko, Kemo</creator><creator>Ceesay, Lamin</creator><creator>Baldeh, Bubacarr</creator><creator>Secka, Ebba</creator><creator>Mackenzie, Grant A</creator><general>Elsevier Ltd</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7RV</scope><scope>7T2</scope><scope>7T5</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88C</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2O</scope><scope>M7N</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20221019</creationdate><title>Attendance and vaccination at immunization clinics in rural Gambia before and during the COVID-19 pandemic</title><author>Osei, Isaac ; Sarwar, Golam ; Hossain, Ilias ; Sonko, Kemo ; Ceesay, Lamin ; Baldeh, Bubacarr ; Secka, Ebba ; Mackenzie, Grant A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c495t-45d113de3d0b8ce462dea730a2aca74fa6897766adceddb79a3a76f0d009bc613</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Antigens</topic><topic>BCG Vaccine</topic><topic>Children & youth</topic><topic>Clinics</topic><topic>Coronaviruses</topic><topic>COVID-19</topic><topic>COVID-19 - epidemiology</topic><topic>COVID-19 - prevention & control</topic><topic>COVID-19 vaccines</topic><topic>Data collection</topic><topic>Electronic vaccination records</topic><topic>Gambia - epidemiology</topic><topic>Health services</topic><topic>Hepatitis</topic><topic>Hepatitis B</topic><topic>Humans</topic><topic>Immunization</topic><topic>Immunization Programs</topic><topic>Immunization Schedule</topic><topic>Immunization services</topic><topic>Infant</topic><topic>Measles</topic><topic>Medical research</topic><topic>Pandemic</topic><topic>Pandemics</topic><topic>Pandemics - prevention & control</topic><topic>Poliomyelitis</topic><topic>Population</topic><topic>Public health</topic><topic>Recovery</topic><topic>Rotavirus</topic><topic>State of emergency</topic><topic>Surveillance systems</topic><topic>Vaccination</topic><topic>Vaccines</topic><topic>Vaccines, Conjugate</topic><topic>Viruses</topic><topic>Whooping cough</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Osei, Isaac</creatorcontrib><creatorcontrib>Sarwar, Golam</creatorcontrib><creatorcontrib>Hossain, Ilias</creatorcontrib><creatorcontrib>Sonko, Kemo</creatorcontrib><creatorcontrib>Ceesay, Lamin</creatorcontrib><creatorcontrib>Baldeh, Bubacarr</creatorcontrib><creatorcontrib>Secka, Ebba</creatorcontrib><creatorcontrib>Mackenzie, Grant A</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Proquest Nursing & Allied Health Source</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Vaccine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Osei, Isaac</au><au>Sarwar, Golam</au><au>Hossain, Ilias</au><au>Sonko, Kemo</au><au>Ceesay, Lamin</au><au>Baldeh, Bubacarr</au><au>Secka, Ebba</au><au>Mackenzie, Grant A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Attendance and vaccination at immunization clinics in rural Gambia before and during the COVID-19 pandemic</atitle><jtitle>Vaccine</jtitle><addtitle>Vaccine</addtitle><date>2022-10-19</date><risdate>2022</risdate><volume>40</volume><issue>44</issue><spage>6367</spage><epage>6373</epage><pages>6367-6373</pages><issn>0264-410X</issn><eissn>1873-2518</eissn><abstract>•Average monthly EPI attendance reduced by 13.4% during the COVID interrupted period.•Average monthly immunizations were reduced by 38.3% during the interruption period.•Highest decline was observed in vaccines given early in infancy.•Reduced EPI attendance during the pandemic interruption period lasted only 3 months.•Mothers were comfortable to re-start EPI attendance with older than younger infants.
The COVID-19 pandemic has affected the delivery of essential health services, such as routine immunization. We assessed the impact of the pandemic on the uptake of routine immunization in rural Gambia.
We collected real-time vaccine administration data in the Basse and Fuladu West Health & Demographic Surveillance Systems from September 01, 2019, to December 31, 2020. We assessed the monthly number of Expanded Program on Immunization (EPI) clinic attendances and vaccines administered, comparing data during the baseline period (September 01, 2019–March 31, 2020), COVID-19 interruption period (April 01–June 30, 2020), initial recovery period (Jul 01–September 30, 2020) and the late recovery period (October 01–December 31, 2020).
Compared to the baseline period, there was an overall average monthly decline of 13.4% in EPI attendance and 38.3% reduction in average monthly immunizations during the interruption period. This decrease was particularly noticeable for Bacille Calmette-Guérin (BCG) (47.2%), birth dose hepatitis B (Hep B) (46.9%), 1st dose pentavalent (Penta1) (43.1%), 1st dose pneumococcal conjugate vaccine (PCV1) (42.4%), and measles vaccines (15.5%). Comparing the late recovery to baseline period, average monthly EPI attendance was 5.3% higher, with 1.9% increase in average monthly immunizations. Monthly immunizations for BCG were 3.0% greater, 2.5% greater for Hep B, 22.7% greater for oral polio vaccine (OPV1), 2.0% less for Penta1, 19.2% less for Penta2, and 2.6% less for PCV1.
The reduced EPI attendance during the pandemic interruption period lasted only 3 months. Significant recovery in EPI attendance occurred during the late recovery period, while rates of monthly immunization returned to pre-pandemic levels for most antigens. EPI programmes should implement strategies to deliver missed antigens when infants do present to EPI clinics, aware that missed doses may be age dependent.</abstract><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>36180374</pmid><doi>10.1016/j.vaccine.2022.09.031</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0264-410X |
| ispartof | Vaccine, 2022-10, Vol.40 (44), p.6367-6373 |
| issn | 0264-410X 1873-2518 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9468317 |
| source | MEDLINE; Elsevier ScienceDirect Journals |
| subjects | Antigens BCG Vaccine Children & youth Clinics Coronaviruses COVID-19 COVID-19 - epidemiology COVID-19 - prevention & control COVID-19 vaccines Data collection Electronic vaccination records Gambia - epidemiology Health services Hepatitis Hepatitis B Humans Immunization Immunization Programs Immunization Schedule Immunization services Infant Measles Medical research Pandemic Pandemics Pandemics - prevention & control Poliomyelitis Population Public health Recovery Rotavirus State of emergency Surveillance systems Vaccination Vaccines Vaccines, Conjugate Viruses Whooping cough |
| title | Attendance and vaccination at immunization clinics in rural Gambia before and during the COVID-19 pandemic |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T00%3A55%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Attendance%20and%20vaccination%20at%20immunization%20clinics%20in%20rural%20Gambia%20before%20and%20during%20the%20COVID-19%20pandemic&rft.jtitle=Vaccine&rft.au=Osei,%20Isaac&rft.date=2022-10-19&rft.volume=40&rft.issue=44&rft.spage=6367&rft.epage=6373&rft.pages=6367-6373&rft.issn=0264-410X&rft.eissn=1873-2518&rft_id=info:doi/10.1016/j.vaccine.2022.09.031&rft_dat=%3Cproquest_pubme%3E2724994148%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2724994148&rft_id=info:pmid/36180374&rft_els_id=S0264410X22011252&rfr_iscdi=true |